Login
Toggle sidebar

Lint: atypical-neurofibromatous-neoplasms-of-uncertain-biologic-potential-annubp

atypical-neurofibromatous-neoplasms-of-uncertain-biologic-potential-annubp
Number Comparisons
error

"increased mitotic count > 1 mitosis/50 HPF but less than < 3 mitoses/10 HPF of 0.51 mm in diameter and 0.2 mm2 in area)"

Line 11:29 · There should never be a space after less and greater than signs.

"increased mitotic count > 1 mitosis/50 HPF but less than < 3 mitoses/10 HPF of 0.51 mm in diameter and 0.2 mm2 in area)"

Line 11:62 · There should never be a space after less and greater than signs.
Acronyms
warning

"Atypical neurofibromas and atypical neurofibromatous neoplasms of uncertain biologic potential (collectively AN/ANNUBP) refer to neurofibromas with atypical histological features. They are considered premalignant with an increased risk of progressing to a malignant peripheral nerve sheath tumour."

Line 1:147 · 'AN' has no definition. Spell it out if it's unfamiliar to the audience.

"Atypical neurofibromas and atypical neurofibromatous neoplasms of uncertain biologic potential (collectively AN/ANNUBP) refer to neurofibromas with atypical histological features. They are considered premalignant with an increased risk of progressing to a malignant peripheral nerve sheath tumour."

Line 1:150 · 'ANNUBP' has no definition. Spell it out if it's unfamiliar to the audience.

"In contrast, the term ANNUBP should be used when atypical changes are encountered in the context of neurofibromatosis type 1 (NF1) 1."

Line 4:26 · 'ANNUBP' has no definition. Spell it out if it's unfamiliar to the audience.

"To make a diagnosis of AN/ANNUBP at least two of the following features need to be identified on histology and immunohistochemistry:"

Line 6:27 · 'AN' has no definition. Spell it out if it's unfamiliar to the audience.

"To make a diagnosis of AN/ANNUBP at least two of the following features need to be identified on histology and immunohistochemistry:"

Line 6:30 · 'ANNUBP' has no definition. Spell it out if it's unfamiliar to the audience.

"increased mitotic count > 1 mitosis/50 HPF but less than < 3 mitoses/10 HPF of 0.51 mm in diameter and 0.2 mm2 in area)"

Line 11:44 · 'HPF' has no definition. Spell it out if it's unfamiliar to the audience.

"increased mitotic count > 1 mitosis/50 HPF but less than < 3 mitoses/10 HPF of 0.51 mm in diameter and 0.2 mm2 in area)"

Line 11:77 · 'HPF' has no definition. Spell it out if it's unfamiliar to the audience.

"Presumably, due to the uncertainty of the biological behaviour of AN/ANNUBP and the inconsistency in the grading nomenclature of neurofibromas and MPNST, they are not given a grade 1."

Line 15:70 · 'AN' has no definition. Spell it out if it's unfamiliar to the audience.

"Presumably, due to the uncertainty of the biological behaviour of AN/ANNUBP and the inconsistency in the grading nomenclature of neurofibromas and MPNST, they are not given a grade 1."

Line 15:73 · 'ANNUBP' has no definition. Spell it out if it's unfamiliar to the audience.

"The imaging characteristics of AN/ANNUBP are intermediate sharing similarities with both localised intraneural neurofibromas and malignant peripheral nerve sheath tumours, and are therefore not repeated here."

Line 17:35 · 'AN' has no definition. Spell it out if it's unfamiliar to the audience.

"The imaging characteristics of AN/ANNUBP are intermediate sharing similarities with both localised intraneural neurofibromas and malignant peripheral nerve sheath tumours, and are therefore not repeated here."

Line 17:38 · 'ANNUBP' has no definition. Spell it out if it's unfamiliar to the audience.
Strong
warning

"Atypical neurofibroma should be used to denote atypical histological features that do not meet the criteria for a malignant peripheral nerve sheath tumour in the setting of sporadic neurofibromas 1."

Line 3:121 · Generally, don't use bold in text: 'malignant<strong> </strong>peripheral nerve sheath tumour'

"The imaging characteristics of AN/ANNUBP are intermediate sharing similarities with both localised intraneural neurofibromas and malignant peripheral nerve sheath tumours, and are therefore not repeated here."

Line 17:143 · Generally, don't use bold in text: 'malignant<strong> </strong>peripheral nerve sheath tumours'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Grading"

Line 13:1 · "Grading" is not a recognised heading for this article type.
Links
0
0
0
0
0
0
2
9
3
0
64
6
0
0
0